Skip to main content

Meeting Highlights

Meeting Highlights

Lung Cancer, ASCO Highlights

Atezolizumab Extends Disease-Free Survival in PD-L1−Positive Early-Stage NSCLC

Phoebe Starr

Meeting Highlights

Prostate Cancer, ASCO Highlights

¹⁷⁷Lu-PSMA-617 Prolongs Survival in Patients with Metastatic Castration-Resistant Prostate Cancer

Phoebe Starr

Meeting Highlights

ASH Highlights, Leukemia

Oral Vodobatinib Elicits Durable Responses in Heavily Pretreated Patients with Chronic Myeloid Leukemia

Meeting Highlights

ASH Highlights, Myelofibrosis

Momelotinib, a Novel JAK Inhibitor, Makes Inroads in Intermediate- or High-Risk Myelofibrosis

Meeting Highlights

ASH Highlights, CAR T-Cell Therapy, Lymphoma

ZUMA-12: Axicabtagene Ciloleucel Shows Substantial Benefit in High-Risk Large B-Cell Lymphoma

Meeting Highlights

ASH Highlights, Clinical Trials, Lymphoma

Step-Up Glofitamab Dosing Induces High Response Rates in Relapsed or Refractory Non-Hodgkin Lymphoma

Meeting Highlights

ASH Highlights, Adverse Events, Transplant

Ruxolitinib in Graft-versus-Host Disease: Practice-Changing Results

Meeting Highlights

ASH Highlights, Myelodysplastic Syndromes

Pevonedistat plus Azacitidine Improves Outcomes versus Azacitidine Monotherapy in High-Risk MDS

Meeting Highlights

ESMO Highlights

Adjuvant Abemaciclib plus Endocrine Therapy Game-Changer in High-Risk, HR-Positive, HER2-Negative Early Breast Cancer

Meeting Highlights

AACR Highlights

Atezolizumab, Vemurafenib, and Cobimetinib Triplet Therapy Improves PFS in BRAF-Positive Melanoma

1
2
3
4
5
6
7

Page 4 of 8
Results 31 - 40 of 72